Proposition 38 would let California borrow $8.4 billion for immunology and immunotherapy research. Here’s what the money would fund, what taxpayers would repay, and what the measure could mean for California families.
Fast Facts
- Election: November 3, 2026
- What it does: Authorizes $8.4 billion in state general-obligation bonds for immunology and immunotherapy research.
- Where the money goes: Half to a selected nonprofit medical research institute affiliated with the University of California and half through grants to eligible public or nonprofit research institutions.
- Research priority: At least half of the research funding must go toward cancer, heart disease and Alzheimer’s disease.
- Estimated taxpayer cost: About $500 million a year for 25 years to repay the bonds.
- Potential benefit: Research could lead to new treatments and discoveries, but there is no guarantee of when—or whether—that will happen.
- Potential California price break: Certain drugs and technologies resulting from the research would have to be sold in California for 20% below the national average price.
Quick Answer
Proposition 38 asks California voters whether the state should borrow $8.4 billion to fund medical research focused on the immune system.
The research would focus on immunology—the study of the immune system—and immunotherapy, which uses the body’s immune system to help fight disease.
At least half of the research money would go toward cancer, heart disease and Alzheimer’s disease. California would repay the bonds from the state’s General Fund at an estimated cost of about $500 million annually for 25 years, according to the official ballot analysis.
The promise is potential future medical breakthroughs.
The tradeoff is that California would pay for that research today, while many of its potential benefits could take years or decades to arrive.
What Is Proposition 38?
Proposition 38 is a general-obligation bond measure.
If approved, California could borrow $8.4 billion to fund immunology and immunotherapy research at California research institutions and universities. The California Legislative Analyst’s Office’s official Proposition 38 analysis describes the measure as allowing the state to borrow the money for medical research conducted by California research institutes and universities.
The money would be divided roughly equally between:
- A nonprofit medical research institute affiliated with the University of California and selected under criteria established by the measure.
- A competitive grant program for eligible public and nonprofit universities and research institutions.
This is important because Proposition 38 is not $8.4 billion for hospitals, health insurance or immediate medical care.
It is primarily an investment in medical research.
What Are Immunology and Immunotherapy?
The terms can sound complicated, but the basic idea is simple.
Immunology is the study of how the body’s immune system works.
Immunotherapy uses the immune system—or substances that affect it—to help fight disease.
The goal of the research funded by Proposition 38 would be to better understand the immune system and develop new medical technologies and treatments.
But there is an important distinction:
Prop. 38 does not guarantee new treatments.
Research can take many years. Some projects produce breakthroughs; others do not.
So voters aren’t being asked whether California should immediately provide a new medical treatment.
They’re being asked whether California should borrow money now to fund research that could produce future medical breakthroughs.
Where Would the $8.4 Billion Go?
The measure divides the funding between two major paths.
1. A selected research institute
Half would go to a qualifying nonprofit medical research institute affiliated with the University of California.
2. Competitive research grants
The other half would support research through grants to eligible public and nonprofit universities and research institutions.
The measure also requires that at least half of the research funding focus on cancer, heart disease and Alzheimer’s disease.
That gives voters a clearer idea of what their money would be intended to accomplish.
How Much Would California Taxpayers Pay?
This is the other side of the proposition.
The state would issue general-obligation bonds, which means California’s General Fund would be responsible for repaying them.
The official fiscal estimate is approximately:
$500 million per year for 25 years
That’s roughly $12.5 billion in total payments if that annual estimate held for the full repayment period. The actual cost could vary depending on interest rates and other factors.
So the simplest way to understand the measure is:
California borrows $8.4 billion today → researchers receive the money → taxpayers repay the debt over time.
The Legislative Analyst’s Office’s Proposition 38 analysis similarly identifies the measure as an $8.4 billion state borrowing program and explains the associated repayment obligations.
Could California Get Some of That Money Back?
Possibly.
Proposition 38 includes provisions designed to give California a financial return if research funded by the program produces commercially successful discoveries.
The state could receive a share of revenue from certain technologies and drugs developed through the research. That money would first help offset the state’s bond costs.
But voters should treat that as a potential benefit, not guaranteed revenue.
A scientific breakthrough could take many years. A project could also fail to produce a commercially successful treatment.
The Legislative Analyst’s Office says the amount and timing of any future revenue are uncertain.
What About Drug Prices?
Proposition 38 contains another provision that could matter to patients.
If technology or drugs developed through the funded research are eventually sold in California, recipients would generally be required to make them available at 20% below the national average price.
That sounds significant—but it comes with an obvious condition:
There has to be a successful product first.
The provision does not immediately lower the price of existing medications.
What Could Proposition 38 Mean for Latino Californians?
Proposition 38 does not specifically target Latino Californians.
Its potential health benefits would be available to Californians generally.
But the measure still matters to Latino communities because diseases such as cancer, cardiovascular disease and other chronic conditions affect Latino families across California.
If research funded by Proposition 38 eventually produces better treatments, Latino patients could benefit from those discoveries along with other Californians.
There is also a broader issue of representation in medical research. Making sure research reflects California’s diverse population can matter when scientists test whether treatments work effectively across different groups.
But Parriva readers should keep one distinction in mind:
Proposition 38 could support research that eventually benefits Latino patients. It does not guarantee better health outcomes for Latino communities.
That is an important difference between a potential benefit and a promised result.
For more context on how medical research and health developments affect Latino families, Parriva’s health coverage regularly examines new research, treatments and health risks affecting California’s Latino communities.
What Are the Arguments for Proposition 38?
The strongest argument for the measure is that medical research can produce benefits far beyond the initial investment.
Supporters can point to the possibility of new treatments, new technologies, jobs and economic activity connected to biomedical research.
They can also argue that California has a major university and biotechnology research infrastructure that could make the state well positioned to turn research funding into discoveries.
The measure also attempts to give California taxpayers something in return through potential future revenue from successful discoveries and lower California prices for certain resulting products.
What Are the Concerns?
The biggest concern is cost versus uncertainty.
California would be committing roughly $500 million a year for 25 years to repay the bonds.
But there is no guarantee that the research will produce a major breakthrough.
There is also an opportunity-cost question:
Could that money be better spent somewhere else?
Critics of large bond measures can argue that long-term debt payments reduce the state’s flexibility to spend money on other priorities, including health care, education, public safety or social services.
The counterargument is that research itself is an investment—and successful discoveries could eventually generate economic and health benefits that exceed the initial cost.
The important point for voters is that both the potential benefit and the potential return are uncertain.
So what Are Voters Deciding?
Proposition 38 is essentially a question about investing in medical research with borrowed money.
A YES vote would allow California to borrow $8.4 billion for immunology and immunotherapy research. The state would repay the bonds through the General Fund at an estimated cost of about $500 million a year for 25 years.
A NO vote would mean California would not issue those bonds for this research program.
The potential upside is significant: new treatments, scientific discoveries and potentially lower prices for certain products developed through the research.
The risk is also straightforward: California would commit billions of dollars today for research whose biggest benefits may not appear for many years—and may never fully materialize.
The simplest way to understand Proposition 38:
California would pay today for the possibility of better medicine tomorrow.
For Latino families, the practical question is not whether Proposition 38 is a “Latino” measure. It isn’t.
The question is whether California’s investment in medical research could eventually produce treatments and discoveries that improve the health of the state’s diverse population—and whether voters believe that potential is worth the long-term cost.
That’s what Proposition 38 puts before California voters on November 3, 2026.
